Skip to content
‹ Back to IndustriesHealthcare

Verified, Tested, Trusted: How Corganics Ensures THC-Free Confidence in Clinical CBD

Corganics develops THC-free, medical-grade CBD products exclusively for healthcare professionals, supported by FDA-registered manufacturing and Advanced Lipid Technology. The company prioritizes rigorous third-party testing and transparency to meet clinical standards rarely found in the broader CBD market. President Reggie Gatewood discusses how these practices build trust and confidence among medical providers.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Corganics on MarketScale.

By Corganics · · Beauty Base Zero Aesthetics & WellnessBrooke WilliamsClinical CbdCorganics
Share

Key takeaways

01

Corganics produces THC-free, medical-grade CBD formulated exclusively for healthcare professional use.

02

Products are manufactured in FDA-registered facilities and validated through rigorous third-party testing.

03

Advanced Lipid Technology enhances bioavailability and consistency in Corganics' cannabinoid formulations.

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Corganics is redefining standards in clinical cannabinoid care with THC-free, medical-grade CBD products developed for use exclusively by healthcare professionals. Backed by Advanced Lipid Technology, FDA-registered manufacturing, and rigorous third-party testing, Corganics offers a level of trust and transparency rare in the CBD space.

In a conversation with Reggie Gatewood, President of Corganics, Brooke Williams, DNP, CRNA, APNP, and founder of Beauty Base Zero Aesthetics & Wellness, asked how providers and patients can be confident there’s truly no THC in the products. Gatewood explained that while hemp and marijuana are related, Corganics uses hemp and a precise extraction process to reduce THC to non-detectable levels—far below legal limits.

Every product includes a QR code linking to full third-party lab results, verifying both purity and safety. These reports confirm the absence of THC, heavy metals, solvents, and pesticides. It’s this level of clinical validation that positions Corganics as the trusted CBD solution recommended by top professionals across wellness and aesthetic medicine.

By combining transparency, safety, and physician-advised formulation, Corganics removes the stigma around CBD and delivers products healthcare providers can confidently stand behind.

Corganics

Part of this channel

Corganics

Medical-grade CBD products developed with healthcare professionals.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

C
Corganics
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Medicus report projects 24% more surgery center cases and 2027 anesthesiology, GI shortages

Medicus report projects 24% more surgery center cases and 2027 anesthesiology, GI shortages

Ambulatory surgery center volumes are projected to rise 24% over the next decade. Shortages in anesthesiology and gastroenterology are projected for 2027. That puts the staffing gap early in the growth period, so for operators planning coverage and outpatient capacity, the nearer 2027 date sets the pace.

  • 01A 24% ten-year forecast and a 9% forecast for 2023 to 2028 measure different windows; check the time frame and start year before putting either in a budget.
  • 02With about nine in ten ASCs at least partly physician-owned, a staffing gap could hit physician owners directly as clinicians and investors.

Oct 30, 2026

TheraPanacea's CEO says software, not hardware, will scale radiotherapy

TheraPanacea's CEO says software, not hardware, will scale radiotherapy

TheraPanacea CEO Nikos Paragios said at ASTRO 2026 in Boston that vendor-agnostic AI software like ART-Plan can raise radiotherapy throughput on existing machines. A February 2025 Lancet Oncology study puts the global linac shortfall at 30%, with 36 of 181 countries owning no linac, limiting how far software alone can go.

  • 01A February 2025 Lancet Oncology study found a global median Linac Shortage Index of 130, a 30% capacity shortfall, and 36 of 181 countries with no linac at all.
  • 02Bundled adaptive systems already exist: Varian’s Ethos won FDA clearance in February 2020 and RaySearch demoed automated replanning at ASTRO, but buyers still need to validate acceptability and sign-off workflows.

Oct 29, 2026

Berg Insight expects 160 million home medical monitors in care programs by 2030

Berg Insight expects 160 million home medical monitors in care programs by 2030

Prescribed connected home medical monitors are forecast to grow from 92.7 million in 2025 to 159.7 million by 2030. Fastest growth is in diabetes, remote ECG and medication compliance, spread across many suppliers. Berg and IoT Business News argue value depends on integrating data into workflows.

  • 01159.7 million prescribed home medical monitors expected by 2030, growing at 11.5 percent annually from 92.7 million in 2025.
  • 02Sleep therapy is the largest connected segment, followed by diabetes with 19.5 million connections at end of 2025, with fastest future growth in diabetes, remote ECG and medication compliance monitoring.
  • 03Clinical value increasingly depends on integrating data across devices into workflows: vendors combine hardware, software, analytics and interoperability with existing healthcare systems.

Oct 26, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

C
Corganics

President, Corganics

Reggie Gatewood is President of Corganics, a company focused on medical-grade CBD products for healthcare professionals. He oversees the development and distribution of THC-free cannabinoid products backed by FDA-registered manufacturing and third-party testing. Gatewood is an advocate for transparency and clinical standards in the cannabinoid industry.

BW
Brooke Williams

Brooke Williams appears in the Corganics conversation alongside Reggie Gatewood, discussing the company's clinical CBD standards and THC-free product line. Further professional details are not confirmed from available sources.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512